Q3 2024 Holdings
Filed 2024-11-14 | 36 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $167.4M | 3,350,000 | 10.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $109.4M | 2,475,000 | 6.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $106.3M | 2,700,000 | 6.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $105.1M | 920,000 | 6.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $104.7M | 4,100,000 | 6.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $96.2M | 940,000 | 6.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $81.4M | 7,539,930 | 5.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $81.2M | 2,900,000 | 5.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $63.6M | 1,260,000 | 4.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $58.5M | 1,988,084 | 3.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $58.0M | 2,550,124 | 3.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $55.0M | 1,618,937 | 3.4% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $45.5M | 8,000,000 | 2.8% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $44.7M | 3,350,000 | 2.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $37.1M | 1,650,000 | 2.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $35.4M | 1,911,433 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $35.2M | 1,800,000 | 2.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $34.1M | 650,000 | 2.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $33.6M | 1,369,714 | 2.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $29.6M | 1,200,000 | 1.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $22.7M | 1,522,332 | 1.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $21.6M | 1,350,000 | 1.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $21.1M | 4,662,073 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $20.5M | 2,000,000 | 1.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $19.4M | 3,410,384 | 1.2% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $18.4M | 1,360,569 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $17.0M | 885,000 | 1.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $17.0M | 290,000 | 1.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $14.8M | 1,284,110 | 0.9% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $10.2M | 150,929 | 0.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $8.4M | 200,000 | 0.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.5M | 750,000 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.2M | 500,000 | 0.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $5.2M | 1,100,000 | 0.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $4.7M | 1,575,000 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $4.6M | 483,000 | 0.3% |